January 2024
1. WU L, Chen M, Lin Y, Zeng B, et al
   Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer.
   Am J Surg Pathol. 2024;48:27-35.
   

   >> Share

   
   October 2023
2. KERVARREC T, Imbeaud S, Veyer D, Pere H, et al
   Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
   Am J Surg Pathol. 2023;47:1077-1084.
   

   >> Share

   
   September 2023
3. WANG Y, Hacking SM, Li Z, Graff SL, et al
   Triple-negative Breast Carcinoma With Apocrine and Histiocytoid Features: A Clinicopathologic and Molecular Study of 18 Cases.
   Am J Surg Pathol. 2023;47:1011-1018.
   

   >> Share

   
   August 2023
4. WEIGELT MA, Sciallis AP, McIntire PJ, Ko JS, et al
   Nipple Adenoma: Clinicopathologic Characterization of 50 Cases.
   Am J Surg Pathol. 2023;47:926-932.
   

   >> Share

   
   July 2023
5. PUN C, Turashvili G, Mulligan AM, Slodkowska E, et al
   Mammary Spindle Cell Proliferations on Core Needle Biopsy: Is Excision Always Necessary?
   Am J Surg Pathol. 2023;47:826-834.
   

   >> Share

   
   March 2023
6. JOEHLIN-PRICE AS, Komforti MK, Ladwig NR, Devine P, et al
   HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
   Am J Surg Pathol. 2023 Mar 20. doi: 10.1097/PAS.0000000000002030.
   

   >> Share

   
   
7. HODA SA, Hoda RS
   "Time Shall Unfold...": The Clinical Value of Grading Mammary Angiosarcoma.
   Am J Surg Pathol. 2023;47:279-280.
   

   >> Share

   
   
8. BARANOV E, Alston ELJ, Lester SC, Fletcher CDM, et al
   Angiomyxoma of the Breast: A Clinicopathologic Analysis of 40 Cases.
   Am J Surg Pathol. 2023;47:296-306.
   

   >> Share

   
   February 2023
9. CALLE C, Zhong E, Hanna MG, Ventura K, et al
   Changes in the Diagnoses of Breast Core Needle Biopsies on Second Review at a Tertiary Care Center: Implications for Surgical Management.
   Am J Surg Pathol. 2023;47:172-182.
   

   >> Share

   
   January 2023
10. SHAKER N, Shafi S, Parkinson B, Chen W, et al
    Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic Carcinoma.
    Am J Surg Pathol. 2023;47:47-54.
    

    >> Share

    
    November 2022
11. PEREZ-MIES B, Caniego-Casas T, Carretero-Barrio I, Biscuola M, et al
    The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.
    Am J Surg Pathol. 2022;46:1545-1553.
    

    >> Share

    
    July 2022
12. BUTCHER MR, White MJ, Rooper LM, Argani P, et al
    MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Am J Surg Pathol. 2022;46:878-888.
    

    >> Share

    
    May 2022
13. ONKEN AM, Collins LC, Schnitt SJ
    Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in Breast Core Needle Biopsies.
    Am J Surg Pathol. 2022;46:637-642.
    

    >> Share

    
    March 2022
14. PARKINSON B, Chen W, Shen T, Parwani AV, et al
    TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
    Am J Surg Pathol. 2022;46:415-423.
    

    >> Share

    
    
15. YASUI H, Kawata T, Muramatsu K, Kakuda Y, et al
    Expression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the Breast.
    Am J Surg Pathol. 2022;46:383-391.
    

    >> Share

    
    December 2021
16. CHUANG AY, Watkins JC, Young RH, Lerwill MF, et al
    Lobular Carcinoma of the Breast Metastatic to the Ovary: A Clinicopathologic Study of 38 Cases.
    Am J Surg Pathol. 2021 Dec 21. pii: 00000478-900000000-97082.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share